GCP
MYGN icon

GSA Capital Partners’s Myriad Genetics MYGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$60K Buy
+11,215
New +$60K ﹤0.01% 1653
2025
Q1
Sell
-26,236
Closed -$360K 1935
2024
Q4
$360K Buy
26,236
+7,816
+42% +$107K 0.03% 1104
2024
Q3
$505K Buy
+18,420
New +$505K 0.04% 899
2020
Q2
Sell
-18,997
Closed -$272K 934
2020
Q1
$272K Buy
18,997
+6,297
+50% +$90.2K 0.07% 544
2019
Q4
$346K Buy
12,700
+3,200
+34% +$87.2K 0.04% 913
2019
Q3
$272K Buy
+9,500
New +$272K 0.04% 987
2019
Q2
Sell
-62,224
Closed -$2.07M 1633
2019
Q1
$2.07M Buy
62,224
+10,999
+21% +$365K 0.21% 58
2018
Q4
$1.49M Buy
51,225
+27,525
+116% +$800K 0.17% 104
2018
Q3
$1.09M Sell
23,700
-37,100
-61% -$1.71M 0.06% 634
2018
Q2
$2.27M Sell
60,800
-20,000
-25% -$747K 0.11% 213
2018
Q1
$2.39M Sell
80,800
-18,258
-18% -$540K 0.13% 196
2017
Q4
$3.4M Buy
99,058
+26,058
+36% +$895K 0.21% 59
2017
Q3
$2.64M Buy
73,000
+600
+0.8% +$21.7K 0.18% 77
2017
Q2
$1.87M Sell
72,400
-49,658
-41% -$1.28M 0.12% 183
2017
Q1
$2.34M Sell
122,058
-28,679
-19% -$551K 0.13% 196
2016
Q4
$2.51M Sell
150,737
-1,302
-0.9% -$21.7K 0.15% 136
2016
Q3
$3.13M Buy
152,039
+6,976
+5% +$144K 0.17% 89
2016
Q2
$4.44M Buy
145,063
+15,735
+12% +$481K 0.25% 26
2016
Q1
$4.84M Buy
129,328
+3,396
+3% +$127K 0.31% 8
2015
Q4
$5.44M Buy
125,932
+49,395
+65% +$2.13M 0.27% 25
2015
Q3
$2.87M Buy
76,537
+28,400
+59% +$1.06M 0.14% 129
2015
Q2
$1.64M Sell
48,137
-12,000
-20% -$408K 0.06% 523
2015
Q1
$2.13M Sell
60,137
-13,011
-18% -$461K 0.08% 316
2014
Q4
$2.49M Buy
73,148
+29,817
+69% +$1.02M 0.17% 90
2014
Q3
$1.67M Buy
43,331
+32,846
+313% +$1.27M 0.09% 252
2014
Q2
$408K Sell
10,485
-1,843
-15% -$71.7K 0.02% 1259
2014
Q1
$421K Sell
12,328
-17,635
-59% -$602K 0.03% 904
2013
Q4
$629K Sell
29,963
-59,193
-66% -$1.24M 0.05% 659
2013
Q3
$2.1M Buy
89,156
+68,648
+335% +$1.61M 0.17% 110
2013
Q2
$551K Buy
+20,508
New +$551K 0.07% 489